Jefferies Highlights Dividend Stocks Benefiting from AI and Aging Trends
Jefferies highlights dividend stocks set to benefit from AI and aging trends, offering stable income and growth potential.
Jefferies Identifies Dividend-Paying Stocks Poised to Capitalize on AI Advancements and Aging Demographics
New York, NY – Investment bank Jefferies has spotlighted a select group of dividend-paying stocks expected to thrive amid the dual forces of artificial intelligence (AI) expansion and a global aging population. These resilient companies, spanning healthcare, consumer staples, and real estate, offer investors stable income streams while positioning for long-term growth in essential sectors less vulnerable to tech disruptions. The analysis, detailed in a recent CNBC report, underscores a strategic pivot toward "old economy" stalwarts as AI hype drives valuation gaps in big tech.
Jefferies analysts argue that AI will supercharge efficiency in labor-intensive industries catering to seniors, such as eldercare robotics and automated home health devices, while demographic shifts—with the UN projecting 1.5 billion people over age 65 by 2050—fuel demand for related products. Simultaneously, these picks provide attractive dividend yields averaging 4-6%, appealing to income-focused investors wary of volatile AI pure-plays like Nvidia or OpenAI partners.
Key Stock Recommendations and Their Tailwinds
Jefferies highlighted several names with strong fundamentals:
-
Kimberly-Clark (KMB): The personal care giant, maker of Huggies and Depend adult diapers, benefits from aging-related demand for incontinence products. AI integration in supply chains could cut costs by 10-15%, per analyst estimates. It boasts a 4.66% dividend yield, 92 consecutive years of payments, and 54 years of increases—a hallmark of Dividend Aristocrat status. Year-to-date gains exceed 7%, outpacing the S&P 500 (Reuters).
-
Vici Properties (VICI): This REIT owns properties leased to Las Vegas casinos and regional gaming venues, where aging baby boomers drive steady visitation. AI-powered personalization in hospitality (e.g., predictive guest analytics) enhances tenant revenues, supporting rent escalators. Offering a 6.06% yield, Vici has raised dividends annually since its 2018 IPO, with tenants proven resilient through recessions (WSJ).
-
Unilever (UL): Despite a recent Underperform rating from Jefferies (price target 4,300 GBp), its aging-focused brands like nutritional supplements stand to gain from AI-driven R&D. Dividend yield hovers at 3.8%, backed by 25+ years of payouts, though pricing pressures temper near-term optimism (Reuters).
Other implied picks from Jefferies' thesis include healthcare firms like Abbott Laboratories (ABT), leveraging AI in continuous glucose monitors for diabetic seniors (yield: 2.1%), and Procter & Gamble (PG) for elder hygiene products (yield: 2.4%).
Past Performance: Proven Resilience Over Flashy Growth
These stocks' track records validate Jefferies' call. Kimberly-Clark delivered 12% annualized total returns over the past decade, including dividends, versus the S&P 500's 11%—with lower volatility (beta of 0.4). During the 2022 bear market, KMB fell just 5% while tech plunged 30%. Vici Properties has compounded 15% annually since IPO, raising dividends 8% yearly amid gaming sector recoveries post-COVID.
Unilever averaged 8% annual returns but lagged in 2025 due to inflation; its 3-year dividend growth rate of 4% remains steady.
Competitor Comparison: Stability vs. High-Flyers
| Stock | Dividend Yield | 5-Yr Annual Return | AI/Aging Exposure | Beta (Volatility) |
|---|---|---|---|---|
| Kimberly-Clark (KMB) | 4.66% | 9.2% | High (adult care) | 0.4 |
| Vici Properties (VICI) | 6.06% | 12.8% | Medium (senior leisure) | 0.9 |
| Nvidia (NVDA) (AI benchmark) | 0.03% | 85% | Pure AI | 1.7 |
| Prologis (PLD) (REIT peer) | 3.2% | 10.5% | Logistics, less aging | 1.1 |
Jefferies notes these picks outperform generic REITs like Prologis in yield while crushing AI hyperscalers on income reliability. Kimberly-Clark edges rival Procter & Gamble in yield (4.66% vs. 2.4%) and aging-specific revenue (15% of sales).
Why Now? Market Timing and Strategic Context
The "why now" stems from AI-induced portfolio rebalancing. Investors face "irrationally wide" valuation gaps—Magnificent Seven stocks trade at 40x earnings vs. 15x for dividend aristocrats—prompting shifts to mitigate AI disruption risks, like job automation in services. Aging accelerates: U.S. 65+ population hits 20% in 2026, per Census data, boosting $8 trillion in annual eldercare spending. Jefferies' call follows Fed rate cuts, favoring yield plays, and AI conferences highlighting geriatric applications.
Skeptics, including Barclays analysts, caution overhyping AI in consumer staples, citing Unilever's margin woes, but consensus from Reuters polls favors defensive yields amid recession fears (60% probability per Goldman Sachs).
Broader Implications for Investors
This thesis signals a maturing AI cycle: from speculative bets to symbiotic applications in unglamorous sectors. For retirees and institutions, these stocks offer 3-5% annual income plus 5-8% growth, hedging against tech corrections. Pension funds like CalPERS have upped allocations 15% to such names in Q1 2026. Risks include regulatory hurdles on AI health data and demographic slowdowns in China, but Jefferies sees 20-30% upside over 12 months.
